Biomedical Engineering Reference
In-Depth Information
43. Kitazawa M, Vasilevko V, Cribbs DH, LaFerla FM (2009) Immunization with amyloid-beta
attebuates inclusion body myositis-like myopathy and motor impairment in a transgenic
mouse. J Neurosc 29(19):6132-6141
44. Sugaya K (2003) Stem cell therapy—a new option for AD patients? In: Richter RW, Richter B
(eds) Alzheimer's disease—the basics. A Physician's guide to the practical management.
Humana Press Spring, Totowa
45. Sugaya K (2005) Stem cell strategies for Alzheimer's disease. In: Hanin I, Cacabelos R, Fisher
A (eds) Recent progress in Alzheimer's and Parkinson's diseases. Taylor & Francis, London,
pp 183-190
46. Pulido JS, Sugaya K (2005) Papel de las celulas madre en la degeneracion macular asociada a
l'edad. In: Mones J, Gomez-Ula (eds) Degeneracion macular asocial a la edad. Prous Science,
Barcelona, pp 343-350
47. Sugaya K (2005) Possible stem cell therapy for Alzheimer's disease and its future direction.
In: Kanazawa I, Shibazaki H, Tougi H (eds) Modern medical treatment in neurology. Brains
Network, Japan, pp 108-114
48. Kwak Y-D, Sugaya K (2006) RNA interference in human NTera-2/D1 cell lines using human
U6 promoter-based siRNA PCR products. Biotechnology and Bioprocess Engineering 2006,
11(3):273-276
49. Kwak Y-D, Choumkina E, Sugaya K (2006) Amyloid precursor protein is involved in stauro-
sporine induced glial differentiation of neural progenitor cells. Biochem Biophys Res Commun
344(1):431-437
50. Kwak Y-D, Kim HM, Qu T, Brannen CL, Soba P, Majumdar A, Kaplan A, Beyreuther K,
Sugaya K (2006) Amyloid precursor protein cause glial differentiation of human neural stem
cell. Stem Cell Dev 15:381-389
51. Sugaya K, Qu K, Sugaya T, Pappas GD (2006) Genetically engineered human mesenchymal
stem cells produce Met-Enkephalin at augmented higher levels in vitro. Cell Transplant
15:225-230
52. Sanchez-Ramos, Raj A (2009) Blood stem cell growth factor reverses memory decline in mice.
The randomized, controlled trial. At:
www.physorg.com/newsn165684042.html
.
Accessed
6 Jun 2012
53. Baier PC, Schindehutte HJ, Thinane K, Flugge G, Fuchs E, Mansouri A, Paulus W, Gruss P,
Trenwalder C (2004) Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats
after transplantation of differentiated mouse embryonic stem cells without morphological inte-
gration. Stem Cells 22:396-404
54. Lindvall O, Bjorklund A (2004) Cell therapy in Parkinson's disease. NeuroRx 1:382-393
55. Polgar S, Morris ME, Reilly S, Bilney B, Sanberg PR (2003) Reconstructive neurosurgery for
Parkinson's disease: a systematic review and preliminary meta-analysis. Brain Res Bull 60:
1-24
56. Zheng X, Cai J, Chen J, Luo Y, Zhi-Bing Y, Fotter E, Wang Y, Harvey B, Miura T, Backman
C, Chen G-J, Rao MS, Freed WJ (2004) Dopaminergic differentiation of human embryonic
stem cells. Stem Cells 22:925-940
57. Peterson DA (2004) Stem cell therapy for neurological disease and injury. Panminerva Med
46(1):75-80
58. Todorovic V, Markovic D, Milosevic-Jovcic N, Petakov M, Balint B, Colic M, Milenkovic A,
Colak I, Jokanovic V, Nikolic N (2008) Matiène æelije zubne pulpe i njihov potencijalni znaèaj
u regenerativnoj medicine. Stomatološki glasnik Srbije 55(3):170-179
59. Anderson KE (2009) Huntington's disease and related disorders. Psychiatr Clin North Am
28(1):275-290
60. Hague SM, Klaffke S, Bandmann O (2005) Neurodegenerative disorders: Huntington's dis-
ease and Parkinson's disease. J Neurol Neurosurg Psychiatry 76:1058-1063
61. Ross CA, Margolis RL (2001) Huntington's disease. Clin Neurosci 1:142-152
62. McMurray CT (2001) Huntington's disease: new hope for therapeutics. TINS 24:S32-S38
63. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinu-
cleotide repeats that is expanded and unstable on Huntington's disease chromosome. Cell
72:971-983
